• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Geographic variations in percutaneous versus surgical coronary revascularization: A global perspective from the SYNTAXES trial.

作者信息

Gragnano Felice, Pelliccia Francesco, Cesaro Arturo, Calabrò Paolo

机构信息

Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy; Division of Cardiology, A.O.R.N. "Sant'Anna e San Sebastiano", Caserta, Italy.

Department of Cardiovascular Sciences, Sapienza University, Rome, Italy..

出版信息

Int J Cardiol. 2023 Jan 15;371:132-134. doi: 10.1016/j.ijcard.2022.09.003. Epub 2022 Sep 9.

DOI:10.1016/j.ijcard.2022.09.003
PMID:36089159
Abstract
摘要

相似文献

1
Geographic variations in percutaneous versus surgical coronary revascularization: A global perspective from the SYNTAXES trial.
Int J Cardiol. 2023 Jan 15;371:132-134. doi: 10.1016/j.ijcard.2022.09.003. Epub 2022 Sep 9.
2
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较：外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
3
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.药物洗脱支架经皮冠状动脉介入治疗与旁路手术治疗 3 支血管病变或左主干病变患者的成本效益：紫杉醇药物洗脱支架与心脏手术（SYNTAX）试验的最终结果。
Circulation. 2014 Sep 30;130(14):1146-57. doi: 10.1161/CIRCULATIONAHA.114.009985. Epub 2014 Aug 1.
4
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗三血管病变或左主干病变患者：多中心随机对照 SYNTAX 试验 10 年随访结果。
Lancet. 2019 Oct 12;394(10206):1325-1334. doi: 10.1016/S0140-6736(19)31997-X. Epub 2019 Sep 2.
5
Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.冠状动脉旁路移植术与经皮冠状动脉介入治疗对三血管病变患者的比较：SYNTAX 试验的最终五年随访结果。
Eur Heart J. 2014 Oct 21;35(40):2821-30. doi: 10.1093/eurheartj/ehu213. Epub 2014 May 21.
6
Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.左主干血运重建经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗慢性肾脏病患者: EXCEL 试验。
J Am Coll Cardiol. 2018 Aug 14;72(7):754-765. doi: 10.1016/j.jacc.2018.05.057.
7
Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease.糖尿病合并复杂冠状动脉疾病患者经皮或手术血运重建后 10 年全因死亡。
Eur Heart J. 2021 Dec 28;43(1):56-67. doi: 10.1093/eurheartj/ehab441.
8
Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.冠状动脉旁路移植术与经皮冠状动脉介入治疗在冠状动脉血运重建中的比较：一项系统评价。
JAMA. 2013 Nov 20;310(19):2086-95. doi: 10.1001/jama.2013.281718.
9
10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification.重度钙化患者行经皮或手术血运重建后 10 年全因死亡率。
JACC Cardiovasc Interv. 2022 Jan 24;15(2):193-204. doi: 10.1016/j.jcin.2021.10.026. Epub 2021 Dec 29.
10
Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: A meta-analysis of randomized trials.经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗左主干冠状动脉疾病：随机试验的荟萃分析。
Am Heart J. 2020 Sep;227:9-10. doi: 10.1016/j.ahj.2020.06.001. Epub 2020 Jun 7.